Peptidoglycan and lipoteichoic acid, components of the streptococcal cell wall, have marked and differential effects on adhesion molecule expression and the production of reactive oxygen species in human whole blood leukocytes
T. Saetre et al., Peptidoglycan and lipoteichoic acid, components of the streptococcal cell wall, have marked and differential effects on adhesion molecule expression and the production of reactive oxygen species in human whole blood leukocytes, SC J CL INV, 60(4), 2000, pp. 311-321
Citations number
28
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
To elucidate the pathophysiology of infections with Streptococcus pyogenes
we applied flow cytometric techniques to study dose-response and time-relat
ed effects of the streptococcal cell-wall-derived components lipoteichoic a
cid (LTA 0.005 to 50 mu g/ml) and peptidoglycan (10 and 100 mu g/ml) on the
expression of leukocyte adhesion molecules, the CD14 receptor, and the pro
duction of leukocyte reactive oxygen species (ROS). LTA (50 mu g/ml, 1-2 h)
markedly increased the expression of CD11b (similar to 5-fold), CD11c (sim
ilar to 2-fold) and CD11a. Concomitantly, CD62L was downregulated (60%). Pe
ptidoglycan alone or in combination with LTA had little effect on adhesion
molecules, except for an amplification of the downregulation of CD62L to 90
%. Monocyte CD14 expression was doubled by LTA. Leukocyte ROS production wa
s 10-fold and 5-fold increased by peptidoglycan in granulocytes and monocyt
es, respectively. LTA alone had no effect, while the combination of peptido
glycan with LTA doubled the increase in ROS caused by peptidoglycan. Conclu
sion: LTA and peptidoglycan had marked and differential effects: LTA caused
mainly adhesion molecule modulation, whereas peptidoglycan mainly increase
d ROS production. These changes are important in inflammatory cell activati
on and recruitment, intracellular microbial killing and adverse tissue inju
ry.